Advertisement
Screener

CURIS, INC. (CRIS) Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax

CURIS, INC. Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax

CURIS, INC. (CRIS) had Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax of $2.00 thousand as of 2017-12-31, per its 10-K filed 2018-03-08.

Discontinued › Notes › Investments

us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax · last filed 2018-03-08

  • 2017-12-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $2.00K.
  • 2017-09-30: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $0.00.
  • 2017-06-30: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $4.00K.
  • 2017-03-31: Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax $5.00K.
Period endAvailable-for-sale Securities, Accumulated Gross Unrealized Loss, before TaxAvailable-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax as first filed
2017-12-31$2.00K
10-K · filed 2018-03-08
2017-09-30$0.00
10-Q · filed 2017-11-07
2017-06-30$4.00K
10-Q · filed 2017-08-03
2017-03-31$5.00K
10-Q · filed 2017-05-04
2016-12-31$6.00K
10-K · filed 2018-03-08
2016-09-30$5.00K
10-Q · filed 2016-11-03
2016-06-30$9.00K
10-Q · filed 2016-08-04
2016-03-31$1.21K
10-Q · filed 2016-05-09
2015-12-31$15.00K
10-K · filed 2017-03-09
$15.56K
10-K · filed 2016-02-29
2015-09-30$1.17K
10-Q · filed 2015-11-09
2015-06-30$17.42K
10-Q · filed 2015-08-06
2015-03-31$15.04K
10-Q · filed 2015-05-07
2014-12-31$15.88K
10-K · filed 2016-02-29
2014-09-30$7.92K
10-Q · filed 2014-11-10
2013-12-31$15.48K
10-K · filed 2015-02-24

Similar stocks

Stock NameCountryMarket CapPE Ratio
Silexion Therapeutics Corp (SLXN)$0.001B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
VivoSim Labs, INC. (VIVS)United States$0.003B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
AIM ImmunoTech Inc. (AIM)United States$0.006B
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70